| Recruiting | Extending Prostate Genetic Awareness, Navigation, and Delivery: The EXPAND Network NCT05627219 | Thomas Jefferson University | — |
| Recruiting | Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patien NCT06067269 | Jonsson Comprehensive Cancer Center | Phase 2 |
| Recruiting | Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BR NCT05806515 | SWOG Cancer Research Network | Phase 2 |
| Recruiting | Focal Ablation With Focal Cryotherapy or HIFU for the Treatment of Men With Localized Prostate Cancer NCT06178354 | Marc Dall'Era, MD | N/A |
| Terminated | MRI Guided Radiation Therapy for the Treatment of High Risk Prostate Cancer NCT05676463 | Thomas Jefferson University | Phase 2 |
| Active Not Recruiting | RElugolix VErsus LeUprolide Cardiac Trial NCT05320406 | Emory University | Phase 2 |
| Suspended | Robot-Assisted Radical Prostatectomy With or Without Vesicopexy in Patients With Prostate Cancer NCT04981834 | University of Southern California | N/A |
| Completed | Pharmacokinetics of IA and IV Ga68-PSMA-11 Infusion NCT04976257 | Ryan Kohlbrenner, MD | EARLY_Phase 1 |
| Recruiting | High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma NCT04945642 | Jonsson Comprehensive Cancer Center | N/A |
| Recruiting | Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Loc NCT04947254 | M.D. Anderson Cancer Center | Phase 2 |
| Recruiting | Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer NCT04725903 | Emory University | N/A |
| Terminated | Health Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation The NCT04927559 | University of Southern California | — |
| Completed | Technology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET Study NCT04447703 | Thomas Jefferson University | N/A |
| Terminated | Randomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer NCT04457245 | Jonsson Comprehensive Cancer Center | Phase 3 |
| Completed | An Investigational Scan (7 Tesla MRI) in Diagnosing Cognitive Impairment in Patients With Non-Metastatic Prost NCT04318028 | University of Southern California | N/A |
| Active Not Recruiting | Lifestyle Behavior Influences Among African American Patients With Stage 0-III Prostate Cancer Survivors and T NCT04189770 | M.D. Anderson Cancer Center | — |
| Withdrawn | Daily, Long-Term Intermittent Fasting for the Prevention of PSA-Recurrence in Patients With Localized Prostate NCT04288336 | Mayo Clinic | EARLY_Phase 1 |
| Completed | Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes NCT04501913 | City of Hope Medical Center | — |
| Active Not Recruiting | Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before NCT03899987 | Roswell Park Cancer Institute | Phase 2 |
| Completed | Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Thera NCT04037254 | NRG Oncology | Phase 1 / Phase 2 |
| Active Not Recruiting | Lifestyle Intervention for the Reduction of Prostate Cancer Disparities Among African Americans NCT04215029 | M.D. Anderson Cancer Center | N/A |
| Completed | A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors NCT03784677 | M.D. Anderson Cancer Center | Phase 1 |
| Completed | Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study NCT03707574 | National Cancer Institute (NCI) | — |
| Completed | Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer NCT04067960 | Mayo Clinic | EARLY_Phase 1 |
| Withdrawn | Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Response NCT03581500 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutati NCT03218826 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatec NCT03570827 | Mayo Clinic | Phase 2 |
| Active Not Recruiting | Watchful Living in Improving Quality of Life in Participants With Localized Prostate Cancer on Active Surveill NCT03575832 | M.D. Anderson Cancer Center | N/A |
| Completed | Daratumumab or FMS Inhibitor JNJ-40346527 Before Surgery in Treating Patients With High-Risk, Resectable Local NCT03177460 | M.D. Anderson Cancer Center | Phase 1 |